Vista Oncology Inc. PS — Olympia, Washington

Vista Oncology Inc. PS is a clinical research site located in Olympia, Washington, United States 98502.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Vista Oncology Inc. PS has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Eli Lilly and Company, ADC Therapeutics S.A..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vista Oncology Inc. PS?

Vista Oncology Inc. PS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vista Oncology Inc. PS conducted?

Vista Oncology Inc. PS has 6 clinical trials on record, with 1 currently active. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Vista Oncology Inc. PS accredited by Crixeo Health?

Yes — Vista Oncology Inc. PS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vista Oncology Inc. PS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.